Stanley Laman Group Ltd. Has $6.35 Million Holdings in Synopsys, Inc. $SNPS

Stanley Laman Group Ltd. lifted its position in Synopsys, Inc. (NASDAQ:SNPS) by 542.9% in the third quarter, HoldingsChannel.com reports. The firm owned 12,877 shares of the semiconductor company’s stock after acquiring an additional 10,874 shares during the period. Synopsys comprises 0.9% of Stanley Laman Group Ltd.’s investment portfolio, making the stock its 22nd largest holding. Stanley Laman Group Ltd.’s holdings in Synopsys were worth $6,353,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Synopsys in the 2nd quarter valued at $647,964,000. Ameriprise Financial Inc. increased its stake in Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after acquiring an additional 585,494 shares during the period. Ninety One UK Ltd acquired a new position in Synopsys in the third quarter worth about $249,851,000. Aspex Management HK Ltd lifted its stake in Synopsys by 106.0% during the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock worth $331,137,000 after purchasing an additional 332,364 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Synopsys by 20.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after purchasing an additional 305,489 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Morgan Stanley increased their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. BNP Paribas began coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Piper Sandler cut their price objective on Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a report on Thursday, December 11th. Needham & Company LLC upped their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.62% of the stock is owned by company insiders.

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $480.42 on Monday. The business has a fifty day moving average of $439.30 and a 200-day moving average of $503.42. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a market cap of $91.91 billion, a PE ratio of 60.13, a price-to-earnings-growth ratio of 4.00 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company’s revenue was up 37.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.